Ophthalmic Screening in Patients with Coronavirus Disease 2019: A Prospective Cohort Study

Postmortem pathological examinations, animal studies, and anecdotal reports suggest that coronavirus disease 2019 (COVID-19) could potentially affect intraocular tissue. However, published evidence is scarce and conflicting. In our study, we screened 100 eyes of 50 patients hospitalized for COVID-19...

Full description

Bibliographic Details
Main Authors: Anthia Papazoglou, Anna Conen, Sebastian Haubitz, Markus Tschopp, Viviane J. Guignard, Marcel N. Menke, Tim J. Enz
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/5/896
_version_ 1797395451053342720
author Anthia Papazoglou
Anna Conen
Sebastian Haubitz
Markus Tschopp
Viviane J. Guignard
Marcel N. Menke
Tim J. Enz
author_facet Anthia Papazoglou
Anna Conen
Sebastian Haubitz
Markus Tschopp
Viviane J. Guignard
Marcel N. Menke
Tim J. Enz
author_sort Anthia Papazoglou
collection DOAJ
description Postmortem pathological examinations, animal studies, and anecdotal reports suggest that coronavirus disease 2019 (COVID-19) could potentially affect intraocular tissue. However, published evidence is scarce and conflicting. In our study, we screened 100 eyes of 50 patients hospitalized for COVID-19. Relevant medical and ophthalmological history was assessed as well as symptoms, laboratory results, specific treatments, clinical course, and outcome. Ophthalmic exams including assessment of best corrected visual acuity (BCVA), intraocular pressure (IOP), color perception, ocular motility, ophthalmoscopy as well as optical coherence tomography (OCT) of the macula and the optic disc was performed at hospital admission and 29 to 192 days later. Of the 50 patients included, 14 (28%) were female. Median age was 64.5 (range 29–90) years. COVID-19 severity was mild in 15 (30%), severe in 30 (60%), and critical in five cases (10%). At baseline, median BCVA was 0.1 (0–1.8) Logarithm of the Minimum Angle of Resolution (LogMAR) and median IOP was 16 (8–22) mmHg. At follow-up, no relevant changes in BCVA and IOP were documented. No signs of active intraocular inflammation or optic nerve affection were found and OCT findings were widely stable during the observation period. Our findings suggest that COVID-19 does not regularly affect intraocular tissue.
first_indexed 2024-03-09T00:34:46Z
format Article
id doaj.art-a2d92ea6a3f84fa3943c10e32e458656
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T00:34:46Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-a2d92ea6a3f84fa3943c10e32e4586562023-12-11T18:15:02ZengMDPI AGJournal of Clinical Medicine2077-03832021-02-0110589610.3390/jcm10050896Ophthalmic Screening in Patients with Coronavirus Disease 2019: A Prospective Cohort StudyAnthia Papazoglou0Anna Conen1Sebastian Haubitz2Markus Tschopp3Viviane J. Guignard4Marcel N. Menke5Tim J. Enz6Department of Ophthalmology, Cantonal Hospital Aarau, 5000 Aarau, SwitzerlandDepartment of Infectious Diseases and Hospital Hygiene, Cantonal Hospital Aarau, 5000 Aarau, SwitzerlandDepartment of Infectious Diseases and Hospital Hygiene, Cantonal Hospital Aarau, 5000 Aarau, SwitzerlandDepartment of Ophthalmology, Cantonal Hospital Aarau, 5000 Aarau, SwitzerlandDepartment of Ophthalmology, Cantonal Hospital Aarau, 5000 Aarau, SwitzerlandDepartment of Ophthalmology, Cantonal Hospital Aarau, 5000 Aarau, SwitzerlandDepartment of Ophthalmology, Cantonal Hospital Aarau, 5000 Aarau, SwitzerlandPostmortem pathological examinations, animal studies, and anecdotal reports suggest that coronavirus disease 2019 (COVID-19) could potentially affect intraocular tissue. However, published evidence is scarce and conflicting. In our study, we screened 100 eyes of 50 patients hospitalized for COVID-19. Relevant medical and ophthalmological history was assessed as well as symptoms, laboratory results, specific treatments, clinical course, and outcome. Ophthalmic exams including assessment of best corrected visual acuity (BCVA), intraocular pressure (IOP), color perception, ocular motility, ophthalmoscopy as well as optical coherence tomography (OCT) of the macula and the optic disc was performed at hospital admission and 29 to 192 days later. Of the 50 patients included, 14 (28%) were female. Median age was 64.5 (range 29–90) years. COVID-19 severity was mild in 15 (30%), severe in 30 (60%), and critical in five cases (10%). At baseline, median BCVA was 0.1 (0–1.8) Logarithm of the Minimum Angle of Resolution (LogMAR) and median IOP was 16 (8–22) mmHg. At follow-up, no relevant changes in BCVA and IOP were documented. No signs of active intraocular inflammation or optic nerve affection were found and OCT findings were widely stable during the observation period. Our findings suggest that COVID-19 does not regularly affect intraocular tissue.https://www.mdpi.com/2077-0383/10/5/896SARS-CoV-2COVID-19ocular involvementretinaoptic nerve
spellingShingle Anthia Papazoglou
Anna Conen
Sebastian Haubitz
Markus Tschopp
Viviane J. Guignard
Marcel N. Menke
Tim J. Enz
Ophthalmic Screening in Patients with Coronavirus Disease 2019: A Prospective Cohort Study
Journal of Clinical Medicine
SARS-CoV-2
COVID-19
ocular involvement
retina
optic nerve
title Ophthalmic Screening in Patients with Coronavirus Disease 2019: A Prospective Cohort Study
title_full Ophthalmic Screening in Patients with Coronavirus Disease 2019: A Prospective Cohort Study
title_fullStr Ophthalmic Screening in Patients with Coronavirus Disease 2019: A Prospective Cohort Study
title_full_unstemmed Ophthalmic Screening in Patients with Coronavirus Disease 2019: A Prospective Cohort Study
title_short Ophthalmic Screening in Patients with Coronavirus Disease 2019: A Prospective Cohort Study
title_sort ophthalmic screening in patients with coronavirus disease 2019 a prospective cohort study
topic SARS-CoV-2
COVID-19
ocular involvement
retina
optic nerve
url https://www.mdpi.com/2077-0383/10/5/896
work_keys_str_mv AT anthiapapazoglou ophthalmicscreeninginpatientswithcoronavirusdisease2019aprospectivecohortstudy
AT annaconen ophthalmicscreeninginpatientswithcoronavirusdisease2019aprospectivecohortstudy
AT sebastianhaubitz ophthalmicscreeninginpatientswithcoronavirusdisease2019aprospectivecohortstudy
AT markustschopp ophthalmicscreeninginpatientswithcoronavirusdisease2019aprospectivecohortstudy
AT vivianejguignard ophthalmicscreeninginpatientswithcoronavirusdisease2019aprospectivecohortstudy
AT marcelnmenke ophthalmicscreeninginpatientswithcoronavirusdisease2019aprospectivecohortstudy
AT timjenz ophthalmicscreeninginpatientswithcoronavirusdisease2019aprospectivecohortstudy